Blue Latitude Health

INSIGHT Our dedicated expert research team conducts in-depth research to generate real customer insight. This insight, together with your business objectives, informs the strategy we recommend and guides the development of customer experience design. From strategic research on brand and strategy, through to communications research or validation of design, we’re on the case.

STRATEGY From product positioning and launch strategies through to capability development, organisational transformation and service design, we’re there to add significant value. Our recommendations are based on substantive qualitative and quantitative research and then made real through a collaborative process, which involves you, alongside our own experts and trusted partners.     
CUSTOMER EXPERIENCE We always begin by using insights drawn from in-depth research to define the problem in the context of your business objectives and customer needs. Then, we design bespoke solutions in an iterative process, enhancing our work as we go. We also validate our solutions with stakeholders and customers, testing to ensure we go above and beyond to delight your customers.

CREATIVE SERVICES We produce ideas that really work - that change people’s behaviour and boost sales, while also creating genuine engagement with your brand. Drawing on in-depth insight, our work is razor-sharp, speaking to your customers’ real needs. Our experience in multinational marketplaces ensures communications are tailored to work effectively in specific media and at all regional and global levels.

We have worked with 14 of the world’s top 20 pharmaceutical companies, including:
Abbvie
AmgenBayer
BMS
Boehringer Ingelheim
Eli Lilly 
Janssen 
Pfizer

See more on our website here: http://bluelatitude.com/clients/

Fishawack Health launches global ‘PsoriasIS NOT CONTAGIOUS’ mask campaign for World Psoriasis Day 2020

Fishawack Health launches global disease awareness campaign, supported by the community of Psoriasis Warriors to de-stigmatize psoriasis during the COVID-19 pandemic.

Fishawack Health, a new breed of global commercialization partner, fit for a post pandemic world

Our parent company, Fishawack Health has reorganized to deliver agile and innovative solutions for life-sciences companies in the face of rapidly changing markets

We've moved!

Blue Latitude Health has moved office to a new location in Barbican, Central London, following a year of substantial growth.

Blue Latitude Health joins Fishawack Group of Companies

Blue Latitude Health announces a new partnership with Fishawack Group of Companies, fuelling our global growth.

Blue Latitude Health hires 7 new members of staff in 2016 Q1

Blue Latitude Health has added seven new full time members of staff in the first quarter of 2016.

Blue Latitude Health to sponsor and co-present in the Innovation Track at ProcureCon Healthcare 2016

Blue Latitude Health’s Managing Director, Martin Brass, and Johnson & Johnson’s Director, David McKimm, to co-present on the topic “Optimising Your Marketing Spend in New Ways to Create Value for Your Customers” at ProcureCon Healthcare conference.

Blue Latitude Health wins PMEA 2015 Innovation award

We are pleased to announce that Blue Latitude Health has won a PMEA 2015 award for our work with Eli Lilly and Company on the Lilly Medical Information Cascade. The project was shortlisted in two categories, ‘Excellence in Physicians/Healthcare Provider Support Programmes’ and ‘Innovation’, winning in Innovation.

Launch of Global Atrial Fibrillation Patient Portal on World Stroke Day

On World Stroke Day, Blue Latitude Health announced the launch of Sign Against Stroke, a patient and carer centric online portal for people impacted by atrial fibrillation. It was developed by the Sign Against Stroke Task Force to empower patients and their family members.

Blue Latitude Health shortlisted for two PMEA 2015 awards

Blue Latitude Health’s Medical Information Cascade project for Eli Lilly and Company has been shortlisted in the Excellence in Physicians/Healthcare Provider Support Programmes and Innovation categories.

Blue Latitude boosts its team

Blue Latitude has appointed Ben Routley, Natalie Seebeck and Kasia Zygadlewicz to its team, following a series of new business wins and increased work from existing clients.

Three strategies for managing loss of exclusivity successfully

Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.

What does the future hold for Medical Affairs?

Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.

Mistrust in medical research: a patient perspective

The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.

Real-world evidence: breaking boundaries in rare disease

Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.

The heavy toll of COVID-19 on cancer patients

We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?

Unpacking rare diseases in the first edition of Delta magazine

Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization

Great creative is effective creative. And effective creative is affective creative

Our creative approach at Fishawack Health is Affective Creativity. Creative crafted to make deep, motivating connections with our target audience. We tap into psychology and combine that with creative craft and expertise and to deliver powerful, engaging work on a conscious as well as a subconscious level.

How to make an impact at a virtual congress

As hard as congress organisers try, replicating the congress experience on a virtual platform is difficult. Rather than trying to replicate the in-person congress experience, the industry has a real opportunity to innovate, leverage the benefits of digital channels, and approach congresses in a completely different way.

In the precision medicine era, the line between products and services is blurred

Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?

Understanding COVID-19 and varying responses across the globe

At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global response to the virus and to ensure we were best positioned to serve our clients during this challenging time. She shares the key learnings and why understanding the epidemiology of the disease is integral for fighting it.

Top 5 tips for a multi-indication product launch

Senior Associate Consultant Sana Rahim and Senior Consultant Victoria Clark explain the lessons the team has learned from launching six different indications of an oncology product in an accelerated timeframe.

If our patients are diverse, why are clinical trials so white?

Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue and calls for the pharmaceutical industry to change its approach.

Engaging physicians during COVID-19

COVID-19 has drastically changed the lives of healthcare professionals. They are emotionally and physically drained and under huge amounts of pressure. They also need pharma’s help. Senior Consultant Pany Koizi outlines five principles for engaging with physicians during the pandemic.

Fishawack Health adds market access and commercial strategy consultancy Skysis as part of its bold growth plans

Fishawack Health, the global healthcare communications agency, announces the acquisition of Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the US.

Perspective: the patient edition

In this issue of Perspective magazine, we explore how the industry can place a greater emphasis on patient-centricity, and how pharmaceutical companies are working with patients across the product lifecycle to develop therapies that better serve their unmet needs.

The ALS patient journey

Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the power of a strong patient community, while explaining how the charity is working with healthcare professionals to support patients, both physically and mentally.

Digital Nation: How Australia became a digital health pioneer

Australia has adopted digital strategies to transform its healthcare system. We sat down with Rachel de Sain, who shares where, and how she contributed to improving digital health products and services in Australia to advance their nation to becoming one of the world's leaders in digital health.

Rethinking Electronic Medical Records

EMR systems are far from perfect. Clinician and PhD candidate Dr. Pao takes us through his perspective on the system and how he aims to lead the way by solving the challenges when adopting this technology in a clinical setting.

Blue Latitude Health moves to new offices in New York

Blue Latitude Health has moved offices to a new location in New York following a year of substantial growth.

Designing a global digital patient services platform

Within our customer experience capability at Blue Latitude Health, our UX researchers and designers are tasked with understanding customer and client needs. Recently, a client required a centralised system to drive the development and deployment of data-driven patient services. Here, we explain the process of developing this platform.

Digital therapeutics and their impact on society

Head of Customer Experience Elisa del Galdo explores how healthcare technology can help chronic disease patients and asks what makes a good digital therapeutic?

Life with multiple myeloma - why I'm a lucky man living the dream

Multiple myeloma patient Bob Munro explains what it's like to live with the rare blood cancer and how his diagnosis led him on the journey of a lifetime – cycling from London to the Arc de Triomphe.

Five key trends in precision and personalised healthcare

Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies can position themselves as leaders at the forefront of these exciting innovations.

Why aren't doctors using digital therapeutics?

The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these tools by healthcare professionals is comparatively low. Senior User Experience Consultant Stewart Anderson explains why.

Launch Excellence 2020

In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch strategy for improving relationships between the customer and the brand.

Precision medicine at Blue Latitude Health

At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.

Understanding the evolving CAR-T market

In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd?

How ready are you for launch?

Pharmaceutical launches are becoming more complex and competitive. Our launch excellence diagnostic tool helps you to map how ready you are for launch, while facilitating success in this challenging environment.

Does your pre-launch strategy really drive behaviour change?

One of the most interesting parts of a pharmaceutical launch is delving into the minds of stakeholders to understand why they behave in the way that they do. Blue Latitude Health Insight Consultant, Dorrotya Okros, examines how we use these insights to understand customers decision making behaviour, in order to make smarter business decisions.

Digitalising healthcare: what can the NHS learn from other industries?

Expensive digital solutions are often disregarded because they do not work well for the end user. Account Manager Fiona Grace explores this challenge and reveals the stories of innovation we can all learn from.

UK vs US: what makes a successful immunisation programme?

Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation programmes in the two countries. She explores the challenges, opportunities for improvement, and asks why vaccination rates are falling.

Are we ready for an Alzheimer's disease modifying treatment

Millions of people across the globe have Alzheimer’s disease and currently, there is no cure. But if a new therapy entered the market today, would healthcare systems be ready for it? Customer Experience Consultant Fadi Haddadeen explores this issue by mapping the patient and neurologist journeys.

Report: Customer experience, shaping digital healthcare

In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance treatment and improve patient and stakeholder outcomes.

The changing face of pharma in the precision era

Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way.

Creative problem solving, solved

Customer Experience Consultant Eimear Power explains how pharma teams can unlock their creativity and foster truly innovative ideas.

Three strategies for managing loss of exclusivity successfully

Claire Taylor, Senior Associate Consultant at Blue Latitude Health explains why you should be strategically planning your LOE strategy years in advance.

Empowered patients: shaking the foundations of healthcare

Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to make a more accurate treatment decision. Here we discuss the barriers, opportunities and potential outcomes of the precision medicine era in healthcare.

A uniquely English genomic medicine service

The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.

Diagnosing the lag in neuropsychiatric treatments

The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.

Precision paediatrics: Treating patients with CAR-T

Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking CAR-T therapy for the first patient in Europe, and how the centre of excellence has adapted to make precision medicine a reality

What does it mean to be an agile organisation

We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market.

Battling breast cancer with precision medicine (Part 2)

Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives his side of the story and explains how industry can help oncologists treat more patients with targeted therapies.

Battling breast cancer with precision medicine (Part 1)

Laura Holmes Haddad is a breast cancer survivor. She made the incredibly brave decision to participate in a PARP inhibitor precision medicine trial. Here, the author and precision medicine advocate tells her story and explains what industry needs to remember when treating cancer patients with precision medicine.

The role of brain health in treating MS

Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health, the importance of a holistic approach to MS and why digital technology is the future of effective MS care.

Diagnosing MS: are we getting it right?

Multi-award-winning patient advocate, Trishna Bharadia, walks through the complications involved with an MS diagnosis, including the challenges for healthcare systems and a handful of insightful patient stories.

Blueprint for healthcare: Brand strategy and planning

This Blueprint for healthcare: brand strategy and planning pack contains two new tools for developing a stakeholder-centric brand, that patients and their HCP's want and need

Empowering the MS patient through shared decision making

Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered

My MS journey: one patient's search for innovation

David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients.

MIT reveals new pill to deliver insulin

A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team and reveals the innovative engineering behind the pill.

Precision medicine from concept to clinic

In our latest edition of ‘Perspective’ magazine, we examine the challenges and opportunities for several stakeholders impacted by the dawn of precision medicine

The problem with the ‘recovery’ conversation in mental health

Account Executive Loredana Gogoescu discusses the impact our language can have on people experiencing mental illness, and asks if terms such as 'recovery' are appropriate.

'Fake news': battling misinformation in healthcare

Blue Latitude Account Executive Ford Stewart explores inaccurate reporting of healthcare innovations and the consequences of fake news for patients, healthcare professionals and the public.

50 questions for delivering an exceptional healthcare brand experience

Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need

The brand strategy revolution

Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need.

How Medisafe is using AI to improve patient adherence

Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.

Downloadable Pack: Understanding Multiple Sclerosis

Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.

Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy

MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget.

Innovative approaches in the treatment of multiple sclerosis

Blue Latitude Health Senior Associate Consultant Will Frostick delves into the MS treatment landscape and explores some of the cutting-edge treatments on the horizon.

Mobilising the public to combat the antimicrobial resistance crisis

Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines this issue and explores what we could do to spark behaviour change.

How Medisafe is using AI to improve patient adherence

Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.

Downloadable Pack: Understanding Multiple Sclerosis

Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.

Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy

MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget.

Innovative approaches in the treatment of multiple sclerosis

Senior Associate Consultant Will Frostick delves into the MS treatment landscape and explores some of the cutting-edge treatments on the horizon.

Q&A with Dr Timothy Vollmer, leading MS Neurologist

Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face when making treatment decisions, and why patients need to be treated with more efficacious drugs earlier on.

Living my best life with multiple sclerosis

Multi-award-winning advocate and patient engagement champion Trishna Bharadia gives a valuable insight into life with multiple sclerosis. She explains how treatment has changed, how our healthcare systems and pharma can unite to improve quality of life for MS patients today, and why her diagnosis isn’t stopping her achieving her goals.

Creative review: ESMO 2018

BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners and giving key insights on how to develop an inspiring design for your booth.

A unique tool for turning data into brand strategy

Head of Insight Martine Leroy, uses her 25+ years’ experience to develop an exclusive perceptual framework for research design and analysis, which generates a deeper understanding of customer needs and the changing market dynamics

Positive disruption: getting to the bottom of big data

BLH speaks to Nicole Huyghe, founder and Managing Director of data science consultancy Boobook, about the growing need from businesses for data-driven decision making.

Navigating the antibiotic resistance crisis

Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating this complex landscape.

Report: Achieving launch excellence in the challenging healthcare markets of today

Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging markets.

Personas: a top tool for personalising pharma marketing campaigns

What everyone forgets about good organisational change in pharma

Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account.

The dark side of direct-to-consumer genetic tests

Direct-to-consumer testing is an affordable way to better understand your DNA, but is this a leap forward in innovation or another layer clouding an already complex market? From anxious patients to unnecessary surgeries, we reveal the barriers for healthcare professionals and patients, and how to solve these industry challenges.

Genetic counsellors: the new healthcare influencers?

Blue Latitude Health explores the relationship between physicians and genetic counsellors, and the impact this has on turning precision medicine into a reality for oncology patients.

Mastering the precision medicine opportunity

The rise of precision medicine will transform the pharma business model, challenging the way we commercialise therapies. BLH Senior Consultant and precision medicine expert David Cooney, reveals how you can plan for this change.

Medopad: the up and coming unicorn transforming remote patient monitoring

Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases.

Bringing the NHS into the 21st century

As the NHS celebrates its 70th birthday and a £20bn “birthday gift” from the UK government, we find out how one company is delivering what the National Health Service really needs – a financially sustainable method of healthcare management. Dr Kruti Patel Clinical Operations Manager at virtual healthcare provider Medefer tells us more.

Successful brands tell stories

Creating a strong brand story is the first step in developing a successful pharma brand. Here, Head of Insight Martine Leroy and Jocelyn Coutinho reveal the tools and techniques they use to create a narrative that makes an impact.

Training the next generation of biotech leaders

Blue Latitude Health speaks to Dr Ivan Wall, Reader in Cell & Gene Therapy Bioprocessing at University College London, to find out about the future of cell and gene therapy, the impact of Brexit, and how the next generation is paving the way for innovation.

Trending: using social media to understand your pharma market

Blue Latitude Health Senior Associate Consultant Jiayi Chen explains how you can use social media to get under the skin of customers and your competition.

The Challenges Of UX In Healthcare: Technology To Change Lives

Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today.

Medical information in precision medicine

Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine.

Behavioural insights to navigate complex healthcare markets

Blue Latitude Health Head of Insight Martine Leroy reveals how her team uses behavioural insights to help develop strong pharma brands and services, which successfully navigate complex situations.

Biotech: it's a people business

Nancy Hunter is the Marketing Director at a cutting-edge pharmaceutical company. Here she explains how a sharp focus on patients’ needs is driving a new operating model for marketing first-in-class drugs, and she describes how her mother’s experience as a cancer patient has shaped her own outlook on healthcare.

Is the pharma business model ready for precision medicine?

Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges and opportunities while introducing the latest issue of 'Perspective' magazine on this weighty topic.

Personas: a top tool for personalising pharma marketing campaigns

Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively.

Does your medical information service work for your users?

Customer Experience Consultant Nilu Davies reveals how you can ensure your medical information service is fit for purpose.

Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies

Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the challenges that come with developing products in this complex market.

Perspective on the power of insight

In this issue of Perspective magazine, our in-house insight experts unite to reveal the best practical tools, tips and knowledge for harnessing insight to empower your customers and inspire innovation.

Commercial innovation in biotech organisations

Blue Latitude Health speaks to Salma Jutt Vice President of US Marketing and Head of Commercial Innovation at a biotech specialising in treating weight loss and obesity.

Big data, privacy and the rise of genomic testing

Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big data.

Lynch syndrome: a patient perspective

Blue Latitude Health intern Costantino Ciotti gives an insight into life with Lynch Syndrome, a genetic condition associated with colon cancer. Here he explores the patient’s perspective, including treatment options, and gives his advice for healthcare professionals diagnosing patients with a genetic disease.

What does programmatic advertising mean for your pharma marketing strategy?

Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns.

How to measure marketing success: profit vs ROI

Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and effectiveness, along with the formula for calculating profit and ROI.

Perspective on biotech leaders

In the latest issue of Perspective magazine, seven industry trailblazers reveal the trends, challenges and opportunities they anticipate in the biotech sector, from empowering patients to deciphering big data.

Global customer research in healthcare: 10 tips for capturing insights that matter

What makes a strong brand? One global core coupled with sensitivity to regions and countries. In part two of our series on customer insight and behaviour change, we share our tips on optimising global customer research projects to ensure you get the balance right in an efficient way.

Achieving deep understanding of healthcare customer behaviour

In part one of a series on customer insight and behaviour change, Martine Leroy reveals a behaviour framework for gathering sharp insights used to help brand managers and marketers achieve their business goals and create a customer-centric strategy.

How do you define a biotech company?

In the coming weeks we will be releasing a report that looks in detail at the commercial challenges and opportunities that a modern day biotech company faces. But before then, we wanted to define the playing field – what actually is a modern-day biotech company?

Perspective on biotech

In this supplementary issue of Perspective, we reveal the emerging technologies taking the biotech world by storm and ask if the definition of a biotech organisation needs updating.

Building a creative marketing consultancy: how we’ve transitioned into a full service global team

In this Q&A, James Atherton, Vice President and Managing Consultant at our New York office, reveals how our NYC and London offices work together and why having a creative services capability has changed the way we deliver strategic work for clients.

Creative effectiveness: how to achieve tangible results

Chris Field, Director and Head of Creative Services at Blue Latitude Health, reveals what it takes to create winning creative campaigns that achieve results in the Pharma market.

How to build an online medical information service that resonates with your customers

Sourcing medical information is a top challenge for healthcare professionals in 2017. Here, Blue Latitude Health Associate Consultant Jiayi Chen gives you the inside scoop on how to build a digital service that really serves the needs of your customers.

Could ketamine be the next big thing in depression?

Account Executive Will Frostick discusses the established treatment model for depression and its limitations, as well as a new entrant poised to revolutionise the field – ketamine.

Creativity in a complex landscape: a pharma perspective

lue Latitude Health interviewed Mohamed Helal, Marketing Lead for Immunology IBVT at EMEA level for Janssen, to find out his view what an exceptional creative campaign looks like when working at the regional.

Creative effectiveness: international work that works

Creative Director Damien Parsonage explains how the creative department at Blue Latitude Health creates work that resonates with customers and delivers results.

Key principles for developing brand and portfolio messaging

Senior Medical Writer Sarah White and Consultant Zoe Bartley reveal practical tips for creating a strong messaging strategy that works for your brand.

Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships

Anne Legendre reviews the scientific rationale behind immunotherapy combinations and Frances Hendry examines how partnerships, co-marketing and positioning drugs will play key roles in shaping the competitive landscape in oncology.

Localising digital services in healthcare: efficient and effective adaptation

Head of Customer Experience Elisa del Galdo explains what localisation means and how pharma companies can effectively and efficiently develop and deploy their services, helping you overcome the challenge of different regions with diverse markets and customers.

How to plan, execute and refine an excellent congress experience

Medical congresses are one of the most important and intensive marketing activities a company can undertake. Here, Account Director Dolan Desai and Senior Creative Copywriter Dale Choate give you the practical tools and tips you need to create a leading congress experience.

21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare

The 21st Century Cures Act has transformed the US drug development landscape. David Cooney explores the implications of the Act for pharmaceutical companies and reveals how it can be leveraged.

Executional Excellence - creating work that works

In the Executional Excellence edition of Perspective magazine, we explore topics around the ‘executional excellence’ theme – creating work that works.

Culture cannot be global: doing business outside your comfort zone

Dorottya Okros of Blue Latitude Health talks through the common communication and negotiation pitfalls of working with Eastern Europe and the CIS for British presenters.

Using service design to improve patients’ quality of life

Customer Experience Consultant Eimear Power talks through the process of developing Orello, a service for metastatic prostate cancer patients and their loved ones, in collaboration with Janssen.

Precision medicine and the changing role of the healthcare professional

The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of the healthcare professional (HCP) in the patient journey? Associate Consultant Ditte Funding discusses challenges and opportunities.

Caring for prostate cancer patients

Although not without its challenges, the appropriate care and support available to patients with prostate cancer is gradually evolving. It’s important not to overlook the all too often ‘unsung heroes’ of prostate cancer; those who care for the patients. Associate Consultant Frances Peters takes a look at the issues and concerns facing the caregivers of those with prostate cancer.

Marketing strategy in complex environments

Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines.

Influence mapping to improve the efficiency and effectiveness of your messaging

As companies work to find innovative marketing techniques to cut through the noise, influence mapping has seen an increase in popularity. Associate Consultant Pany Koizi talks through how to get the most out of the influence mapping process.

Rise of the patient expert - an interview with Michael Seres

Founded by Michael Seres in 2011, 11 Health is a connected medical device company currently working to change the lives of patients using stoma bags. Content Marketing Manager Liz Inskip interviews Michael about how patients are changing the role of the expert in healthcare, and the systematic barriers to innovation in healthcare.

From first conversation to the cover of TimeOut London: #Kisses4wishes to support Rays of Sunshine

As a business that works with healthcare and pharma companies, it’s not often that we get the opportunity to design the cover for Time Out London, so we jumped at the chance to partner with Rays of Sunshine to help them get the word out about their #Kisses4Wishes campaign on Valentine’s Day. Liz Inskip talked with the creative team about the campaign and how BLH approaches this kind of work.

The changing role of the expert in healthcare: challenges in customer-centricity

When we talk about customers as experts in healthcare, what we’re really talking about are clinicians. Experts in diagnosis, treatment and clinical care (HCPs) and experts as those who experience the medical condition in their own personal context (patients). Head of Customer Experience Elisa del Galdo talks through how the evolution of the relationship between HCPs and patients is changing the role of the expert in healthcare.

Is fear an effective driver of behaviour change?

Client Lead Natalie Seebeck explains that applying fear-based models in communications can be effective, if the right components are used in the right way.

Smart connections with a human touch

Simon Young, Director at Blue Latitude Health, discusses how advances in technology are influencing the future of the expert-patient relationship and why healthcare businesses must evaluate how best to support the future role of the expert.

Patient-centred care innovation in dementia: a conversation with Neil Maiden

Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators in this therapy area are.

Introduction to the manufacturing of biologics

The last decade has seen the rapid growth of biologics in the pharma market, making them a key sector to watch. With their growing popularity, it’s important to understand the opportunities and threats they present. Associate Consultant Ditte Funding takes us through how biologics are made, what makes them unique, and what it all means for pharma companies.

2017 Trends in healthcare – how advances in technology are influencing the expert-patient relationship

In the 2017 trends edition of Perspective magazine, we explore how advances in technology are influencing the future of the expert-patient relationship and the role healthcare businesses can take in supporting and enhancing these interactions at the point of need.

Living with Crohn's disease: a patient perspective

Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person, and investigates what’s being done to tackle the gaps in treatment options for patients.

Are we harnessing the full emotional power of brand creativity?

Creative Director Damien Parsonage breaks down the common misconception that pharma and healthcare marketing for healthcare professionals ought to be entirely scientific and rational. Brands are powerful; here's how to strengthen yours by infusing it with emotion.

Are reverse auctions the best way to procure marketing services?

Managing Director Martin Brass discusses what a reverse auction is, and whether it truly is a good way for healthcare companies to drive efficiencies when procuring marketing services.

Artificial Intelligence: the new healthcare algorithm

The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare. Associate Medical Copywriter Kulveer Singh dives deeper into the technology.

DAM and CMS: managing assets to maximise adoption and value

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised to maximise outcomes for pharma and agencies.

Alzheimer’s disease: reviewing the immediate treatment horizon

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

A stumble, but not a fall – what’s next for Opdivo?

Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.

Immuno-oncology; bringing patients closer to treatment

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?

Products as portfolios: positioning immuno-oncology products

The last few years have seen a huge proliferation in the number of products entering the oncology space, with a lot more currently being investigated in clinical trials. Effective positioning in this situation is vital to cut through the noise, so we've outlined some key learnings from our extensive experience in this area.

Immunotherapy in oncology

Consultant David Cooney explores the medical insights, unmet needs, and future of the vastly growing area of immunotherapy as the fourth pillar in oncology.

European prostate cancer treatment is changing - what are the opportunities for marketers?

Consultant Jeremy Poland examines some of the key dynamics in prostate cancer multi-disciplinary teams across Europe and how the recent trends impact the opportunities available to healthcare marketers.

Alzheimer's: the numbers we cannot forget

In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as looking at the some of the glimmers of light at the end of the tunnel.

Biosimilars - the Brexit of the pharmaceutical industry?

In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities of Britain exiting the EU (Brexit).

Why isn't your segmentation working?

How to develop an actionable segmentation for pharma and healthcare marketing that delivers real commercial value.

The role of empathy in the design of products and services

Peter Timmer of Blue Latitude Health talks through what it means to design with empathy for the customer, and why it produces better products and services.

Experience design of physical spaces: a human-centred approach

Anna Tamasi from Blue Latitude Health highlights the key considerations and best practices for spatial design from a user experience design perspective.

Focus on immunotherapies: special magazine from Blue Latitude Health

Blue Latitude Health have worked with four of the eight immunotherapies currently approved by the FDA, so we've pooled our expertise across the different capabilities to give you a clear view on the fourth pillar of care in oncology.

The difference between market intelligence and design intelligence

Blue Latitude Health's Elisa del Galdo explains how market and customer research differ, and in which situations you would use one over the other.

Delivering a better eDetail: Strategy-led user-centred methodology in practice

Stuart Goodman and Anna Tamasi demonstrate how user-centred design helps to build better strategy and assets for pharma and healthcare.

Understanding personas for healthcare

In this article, Head of Insight Martine Leroy tackles the persona. Here, she breaks down for us what a persona is in the context of customer-centric design, and addresses some frequently asked questions about these and other tools used for improving customer engagement.

What are the benefits of running workshops for international teams?

Frances Hendry of Blue Latitude Health takes a deeper look at the benefit of workshops and how clients can use them as a tool to develop cross-functional alignment, reach ideas, and define projects more quickly.

Client relationships in the ever-changing marketing landscape

Client Lead Ben Routley talks about what Blue Latitude Health do to set ourselves apart, and what our secret to building long-lasting client relationships is.

Measurement and optimisation for digital marketing success in the pharmaceutical industry

In this article, Jiayi Chen explains why you need a measurement plan for your digital marketing efforts, and the key steps and common issues in developing a measurement framework for assessing digital marketing success.

Download 'Perspective magazine issue 2: Human-centred design and strategy'

In the second issue of Perspective, the digital magazine from Blue Latitude Health, we tackle topics dealing with customer experience and customer and patient centricity.

Adjusting to change in healthcare: Learning from translational research

In this article, Blue Latitude Health's Head of Insight, Martine Leroy, explores how pharma could learn from translational research organisations in adapting their approach to the changing healthcare landscape.

Focus on multiple myeloma treatment: Witnessing a transformation

Consultant David Cooney of Blue Latitude Health will take you through how that transformation has happened, and where the treatment of multiple myeloma is heading.

The ROI of user experience in pharma and healthcare: How to engage your customers

In this article, Head of Customer Experience Elisa del Galdo of Blue Latitude Health breaks down how to understand the return on investment of user experience in pharma and healthcare.

Why does content need a strategy?

Not all organisations are in a position to look at maturity – for some, there’s still a pressing question that needs answering: Why does content need a strategy? Content Marketing Manager Liz Inskip and guest blogger Adwoa Baah explain.

Issues facing brand teams and how agencies help to deliver value

We interviewed Wayne Atherden, Procurement Director Commercial Services at Janssen, to get his view on the issues facing brand teams and how agencies help to deliver value.

Beyond the patient journey: Designing for behaviour change

In 2016, it’s time to update our model for the customer journey. Customer Experience Consultant Anna Tamasi talks us through the future of journey mapping.

Brand teams: They're not what you think they are

Head of Commercial Matt Bolton of Blue Latitude Health breaks down what we mean when we talk about eliminating the last silos in pharma marketing.

Why are doctors frustrated with the digitalisation of healthcare?

In this article, Customer Experience Consultant Anna Tamasi from Blue Latitude Health highlights the most common usability and user experience implications that the digitalisation of healthcare poses on doctors professional lives.

What pharma needs to know about genomic data in 2016

Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016.

Content Strategy for pharma: Maturing your approach in 2016

In this article, Consultant Adwoa Baah and Content Marketing Manager Liz Inskip take us through three things pharma can do to improve content strategy maturity within their organisations in 2016.

Key topics and trends for pharma and healthcare in 2016

Introducing PERSPECTIVE, the new digital magazine from Blue Latitude Health. A step beyond identifying top trends, this magazine explores key topics for 2016 for pharma and healthcare companies.

Regional campaigns: Improving local uptake while staying on-message

Senior Account Manager Dolan Desai talks us through the five core considerations that will allow you to maximise your campaign's impact across a region through coherent execution.

10 tips for developing insightful pre-launch positioning

By getting your positioning right, you can build the motivational, aspirational, and resonant brand story and messaging that will allow your product to become a brand. Blue Latitude Health's Head of Insight, Martine Leroy, delivers her top tips on how to keep insight at the centre of your positioning to best support your brand.

Bigger than brand: Portfolio Positioning for Pharma

Senior Consultant Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

Tackling biosimilars – how to handle the threat to Pharma brands

Strategy Consultant Mark Assenti outlines three key points for developing a strategy to tackle the threat to Pharma brands from biosimilars.

Patient-Centricity: Improving the model with patient journeys

Head of Customer Experience Elisa del Galdo takes us through a better way to look at patient-centricity: with the patient's journey at the centre.

Innovating with what you have: better healthcare with existing technology

Senior Account Executive Will Taylor talks us through a case study in applying established technology to healthcare problems in an innovative way.

How to nail pre-launch positioning in Pharma

Head of Commercial Matt Bolton lays out three key points for getting your pre-launch positioning right in Pharma and healthcare.

ASCO 2015: What you missed in Chicago

Blue Latitude sent two of our consultants to Chicago to attend ASCO 2015, a key annual meeting for oncology specialists that brings over 30,000 delegates together to talk about innovations and progress in the field. David takes us through the highlights of the event and his take on the exciting developments that came out of the conference.

How do you solve a problem like non-adherence? Part 2

Following her previous piece on patient medical non-adherence, Head of Customer Experience Elisa del Galdo takes a look at the different patient personas that emerge during the diagnosis and treatment pathway. Download her sketchnote of the three personas and read about how to design services for unengaged patients.

How do you solve a problem like non-adherence? Part 1

Recent research from the World Health Organisation and the Mayo Clinic on the impact of (and influences on) a patient’s ability to adhere to their treatment regime has shown that an astounding amount of patients do not follow or complete their treatment as prescribed. Head of Customer Experience Elisa del Galdo looks at the factors around patient non-adherence and how Pharma can help to solve the problem.

How to design patient services with social media within the ABPI code guidelines

In this blog, Senior Consultant Craig Moore, from the Blue Latitude Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services.

Evolution of the wearable tech revolution

Stuart Goodman delves into the world of wearables, further analysing what role they play in pharma’s future.

Not all data is created equal

Aurélie Pols from Mind Your Privacy has written this guest blog post on data privacy and security, and specifically the risks of HIPAA or PII non-compliance, in both the USA and Europe.

Use of biomarkers in marketing

Mark Assenti talks about utilisation of biomarkers in marketing is a trend that we have seen growing in 2014 and expect to hear even more about into 2015.

How the focus on patient outcomes has allowed FMCG to enter into healthcare market

Associate Consultant Mette Drabæk talks about how the increase in ability to measure real-world patient outcomes has strengthened the position of the payer when negotiating reimbursement contracts with pharma companies.

Top 7 Trends in Pharma Marketing for 2015

Toward the end of 2014 the Blue Latitude team gathered together for breakfast in the boardroom to discuss how pharma marketing will change in the year ahead and what trends will be big in pharma marketing during 2015.

Take the Multichannel Health Check

Complete the Multichannel Health Check to find out what type of marketer you are and receive expert advice on how to get to the next step.

How to prepare and execute a multichannel campaign

You may be familiar with digital marketing, however Multichannel Marketing is quite different.

3 Steps to Navigating Multichannel in Healthcare

You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign.

Guide to Customer Experience for Pharma

Find out how to overcome your customer experience challenges

The invisible customer

Find out why internal stakeholders are key to Pharma marketing success.

Developing multichannel capability in Pharma

Find out how training could give your team the confidence, knowledge and skills to overcome your organisation's multichannel challenges.

A guide to developing customer-centred, multichannel marketing

Find out how a balanced approached to multichannel marketing could benefit your brand - the customer's agenda is just as important as Pharma's and needs to be listened to in order to create value for your brand.

A Pharma Marketer's Guide to the Mobile Web

Despite an acknowledgement of the importance of mobile by the pharma sector, there has been little evidence to show that businesses are harnessing the mobile web effectively, instead opting for mobile app development. This guide sheds some light on mobile web opportunities for Pharma.

Marketing Automation for Pharma

With Pharma Marketers increasingly being asked to do more with fewer resources, Marketing Automation is a key area that needs to be explored. Find out how it could help you to streamline, automate, and measure marketing tasks for increased operational efficiency and faster revenue growth.

How to Master Multichannel Marketing in Pharma

Learn how to optimise your multichannel marketing for increased profitability and improved customer engagement.

“I was very impressed by the team’s ability to connect the big, strategic picture with the practical choices we could make as an operating company. Blue Latitude ensured we accurately understood the future of healthcare in the UK and helped us decide what direction we wanted to take."

Irina Osovskaya
Digital Manager 
Janssen UK & Ireland 


‘’Your collaborative approach bought the best out of our cross-functional teams and you delivered an actionable multichannel planning framework and tools based on extensive industry experience and subject matter expertise.’’

Tim Jantsch Director, Global Customer Excellence,
Abbvie

"Blue Latitude were engaged for the research and user testing for our diabetes site. The knowledge and expertise of the entire account team involved in the project was second-to-none and every team member added a huge amount of value to the project. The project ran extremely well; on-time with regular updates from the team, milestones delivered to a very high standard and on-budget. I wouldn’t hesitate to recommend them to anyone who needs assistance in developing their web strategy."

Jason Lovatt
Brand Lead, Blood Glucose Monitoring
Sanofi UK & Ireland


"What you advised us to do has been adopted throughout our business. You have been absolutely brilliant and impeccable on deadlines. Working with you on this project has been overwhelmingly positive, rewarding and enjoyable. Thank you."

Brand Manager
Top 5 Pharma company"Wonderful!  Again, excellent job by the entire team today.  We feel confident in the team, inspired by your vision, and excited to have you join us on this new multichannel journey for the brand’’

Chris McNeal,
Commercial Strategy Leader, Immunology‘’You are a valued partner and great to work with. You have helped us to form our strategic vision and provided a different approach to implementing a framework for our multichannel capabilities’’

Mark PetersenSenior Global Business ManagerBoehringer Ingelheim  

‘’The insights and the customer journeys you presented have been invaluable and helped the whole team understand the behaviours, motivations and needs of our key stakeholders.  Thank you’’

Mike Yates,
Director, Global Marketing and Market Access Team LeadUCB 

’You have been accountable and responsible, setting the agenda and working with us as a real partner.“

Jorge Herrera, Senior Director
Global Channels Team Lead, Enterprise Multi Channel MarketingPfizer 
"I am ecstatic with the work. You have an extremely professional team who have completely understood the culture and business objectives of the Parkinson’s Movement and have helped us map the behaviour of people with Parkinson’s and their use of the internet’’

Tom Isaacs, 
President of the Cure Parkinson’s Trust